INNOSPEC INC. (IOSP) Spending and interest coverage
- R&D / revenue · 12 months: Value 2.83%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.42%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 2.83% | Research and development expense / revenue. Period ending 2026-06-30. $52.10M ÷ $1.84B × 100 ≈ 2.83% |
| Stock-based compensation / revenue · 12 months | 0.42% | Share-based compensation / revenue. Period ending 2026-06-30. $7.80M ÷ $1.84B × 100 ≈ 0.42% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 52.10M USD | Research and Development Expense |
| Revenue | 1.84B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 7.80M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 128.90M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $52.10M | $1.84B | $7.80M | $128.90M | (m) | 2.83% | 0.42% | (m) | (m) |
| 2026-03-31 | $51.50M | $1.79B | $7.80M | $123.50M | (m) | 2.88% | 0.44% | (m) | (m) |
| 2025-12-31 | $51.00M | $1.78B | $8.10M | $129.50M | (m) | 2.87% | 0.46% | (m) | (m) |
| 2025-09-30 | $46.20M | $1.79B | $7.10M | $123.80M | (m) | 2.58% | 0.40% | (m) | (m) |
| 2025-06-30 | $46.10M | $1.79B | $8.40M | $163.50M | (m) | 2.57% | 0.47% | (m) | (m) |
| 2025-03-31 | $46.50M | $1.79B | $8.30M | $169.90M | (m) | 2.60% | 0.46% | (m) | (m) |
| 2024-12-31 | $47.80M | $1.85B | $8.50M | $177.90M | (m) | 2.59% | 0.46% | (m) | (m) |
| 2024-09-30 | $44.00M | $1.87B | $8.50M | $181.30M | (m) | 2.35% | 0.45% | (m) | (m) |
| 2024-06-30 | $44.50M | $1.89B | $8.30M | $177.60M | (m) | 2.35% | 0.44% | (m) | (m) |
| 2024-03-31 | $42.90M | $1.94B | $8.20M | $171.10M | (m) | 2.21% | 0.42% | (m) | (m) |
| 2023-12-31 | $41.70M | $1.95B | $8.00M | $161.60M | (m) | 2.14% | 0.41% | (m) | (m) |
| 2023-09-30 | $41.20M | $1.96B | $7.90M | $163.70M | (m) | 2.10% | 0.40% | (m) | (m) |
| 2023-06-30 | $39.70M | $2.01B | $7.40M | $171.90M | (m) | 1.97% | 0.37% | (m) | (m) |
| 2023-03-31 | $39.20M | $2.00B | $6.90M | $184.00M | (m) | 1.96% | 0.34% | (m) | (m) |
| 2022-12-31 | $38.70M | $1.96B | $6.70M | $187.30M | (m) | 1.97% | 0.34% | (m) | (m) |
| 2022-09-30 | $39.80M | $1.87B | $4.50M | $176.20M | (m) | 2.13% | 0.24% | (m) | (m) |
| 2022-06-30 | $40.00M | $1.73B | $4.70M | $157.50M | (m) | 2.31% | 0.27% | (m) | (m) |
| 2022-03-31 | $38.50M | $1.62B | $4.50M | $148.20M | (m) | 2.38% | 0.28% | (m) | (m) |
| 2021-12-31 | $37.40M | $1.48B | $4.40M | $132.10M | (m) | 2.52% | 0.30% | (m) | (m) |
| 2021-09-30 | $34.40M | $1.38B | $6.00M | $126.00M | (m) | 2.49% | 0.43% | (m) | (m) |
| 2021-06-30 | $31.80M | $1.27B | $5.90M | $111.40M | (m) | 2.50% | 0.46% | (m) | (m) |
| 2021-03-31 | $31.30M | $1.16B | $6.20M | $21.00M | (m) | 2.70% | 0.53% | (m) | (m) |
| 2020-12-31 | $30.90M | $1.19B | $5.80M | $33.70M | (m) | 2.59% | 0.49% | (m) | (m) |
| 2020-09-30 | $32.80M | $1.27B | $6.10M | $48.10M | (m) | 2.58% | 0.48% | (m) | (m) |
| 2020-06-30 | $34.80M | $1.38B | $6.20M | $69.50M | (m) | 2.52% | 0.45% | (m) | (m) |
| 2020-03-31 | $34.90M | $1.50B | $6.20M | $154.60M | (m) | 2.33% | 0.41% | (m) | (m) |
| 2019-12-31 | $35.40M | $1.51B | $6.60M | $149.90M | (m) | 2.34% | 0.44% | (m) | (m) |
| 2019-09-30 | $35.30M | $1.52B | $6.80M | $149.00M | (m) | 2.33% | 0.45% | (m) | (m) |
| 2019-06-30 | $33.70M | $1.51B | $6.20M | $144.20M | (m) | 2.23% | 0.41% | (m) | (m) |
| 2019-03-31 | $34.20M | $1.50B | $5.70M | $140.80M | (m) | 2.27% | 0.38% | (m) | (m) |
| 2018-12-31 | $33.40M | $1.48B | $4.90M | $133.50M | (m) | 2.26% | 0.33% | (m) | (m) |
| 2018-09-30 | $32.70M | $1.44B | $3.70M | $132.50M | (m) | 2.28% | 0.26% | (m) | (m) |
| 2018-06-30 | $32.50M | $1.41B | $3.80M | $128.10M | (m) | 2.31% | 0.27% | (m) | (m) |
| 2018-03-31 | $32.30M | $1.37B | $3.90M | $133.30M | (m) | 2.35% | 0.28% | (m) | (m) |
| 2017-12-31 | $31.40M | $1.31B | $4.10M | $129.70M | (m) | 2.40% | 0.31% | (m) | (m) |
| 2017-09-30 | $29.60M | $1.19B | $3.90M | $123.60M | (m) | 2.49% | 0.33% | (m) | (m) |
| 2017-06-30 | $28.20M | $1.06B | $3.60M | $112.30M | (m) | 2.65% | 0.34% | (m) | (m) |
| 2017-03-31 | $25.90M | $965.60M | $3.40M | $106.20M | (m) | 2.68% | 0.35% | (m) | (m) |
| 2016-12-31 | $25.40M | $883.40M | $3.30M | $105.40M | (m) | 2.88% | 0.37% | (m) | (m) |
| 2016-09-30 | $25.60M | $891.60M | $3.80M | $107.40M | (m) | 2.87% | 0.43% | (m) | (m) |
| 2016-06-30 | $25.70M | $940.30M | $3.80M | $129.70M | (m) | 2.73% | 0.40% | (m) | (m) |
| 2016-03-31 | $26.00M | $955.20M | $3.70M | $158.50M | (m) | 2.72% | 0.39% | (m) | (m) |
| 2015-12-31 | $25.30M | $1.01B | $3.70M | $156.30M | (m) | 2.50% | 0.37% | (m) | (m) |
| 2015-09-30 | $24.20M | $1.06B | $3.60M | $166.00M | (m) | 2.29% | 0.34% | (m) | (m) |
| 2015-06-30 | $23.60M | $1.03B | $3.20M | $150.00M | (m) | 2.29% | 0.31% | (m) | (m) |
| 2015-03-31 | $22.70M | $1.01B | $2.90M | $117.90M | (m) | 2.25% | 0.29% | (m) | (m) |
| 2014-12-31 | $22.20M | $960.90M | $2.60M | $112.50M | $3.80M | 2.31% | 0.27% | 29.61× | Reported |
| 2014-09-30 | $21.90M | $911.80M | $2.30M | $95.10M | $3.70M | 2.40% | 0.25% | 25.70× | Reported |
| 2014-06-30 | $21.60M | $876.40M | $2.30M | $89.40M | $3.30M | 2.46% | 0.26% | 27.09× | Reported |
| 2014-03-31 | $21.30M | $840.10M | $2.40M | $86.40M | $2.90M | 2.54% | 0.29% | 29.79× | Reported |
| 2013-12-31 | $21.20M | $818.80M | $2.50M | $90.60M | $2.30M | 2.59% | 0.31% | 39.39× | Reported |
| 2013-09-30 | $21.80M | $790.90M | $2.60M | $89.80M | $1.90M | 2.76% | 0.33% | 47.26× | Reported |
| 2013-06-30 | $20.90M | $781.50M | $2.90M | $87.60M | $1.80M | 2.67% | 0.37% | 48.67× | Reported |
| 2013-03-31 | $20.60M | $775.00M | $3.00M | $89.40M | $1.80M | 2.66% | 0.39% | 49.67× | Reported |
| 2012-12-31 | $19.60M | $776.40M | $3.10M | $98.40M | $1.80M | 2.52% | 0.40% | 54.67× | Reported |
| 2012-09-30 | $19.00M | $763.20M | $3.20M | $96.10M | $2.40M | 2.49% | 0.42% | 40.04× | Reported |
| 2012-06-30 | $18.90M | $781.90M | $3.10M | $58.60M | $2.80M | 2.42% | 0.40% | 20.93× | Reported |
| 2012-03-31 | $18.60M | $789.90M | $3.00M | $56.90M | $3.30M | 2.35% | 0.38% | 17.24× | Reported |
| 2011-12-31 | $18.30M | $774.40M | $3.10M | $49.60M | $3.90M | 2.36% | 0.40% | 12.72× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $17.60M | $683.20M | $800.00K | $72.20M | $5.10M | 2.58% | 0.12% | 14.16× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $16.40M | $598.50M | $1.50M | $20.70M | $6.30M | 2.74% | 0.25% | 3.29× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| Perimeter Solutions, Inc. (PRM) | $4.593B | -17.21 | |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |
| CitroTech Inc. (CITR) | United States | $0.097B | -5.12 |
| Loop Industries, Inc. (LOOP) | $0.023B | -5.50 |